Atypical Ductal Hyperplasia
Original Article Expression of ALDH1 in atypical ductal hyperplasia, carcinoma, usual ductal hyperplasia and normal breast duct
9
Atypical Ductal Hyperplasia of the Breast: Management of a Clinical Case at the IBN SINA Hospital Centre with Literature Review
7
Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy
5
Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast
9
Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
11
Original Article D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion
8
The diagnosis and management of pre invasive breast disease Genetic alterations in pre invasive lesions
7
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor negative cancers in BRCA1 mutant mice
18
Detection of monoclonal microsatellite alterations in atypical breast hyperplasia
7
Situs Invertus Totalis in a Patient with Bilateral Papillary Serous Cystadenocarcinoma Ovary: Rare Association with Review of Literature
6
Gains and Losses of HLA Class II (DR) and CD4 in Atypical Hyperplasia, Carcinoma in situ and Infiltrating Ductal Carcinoma of the Breast
6
Evaluation of breast cancer risk associated with atypical hyperplasia of the lobular and ductal types in a jamaican hospital 2007 2012: across sectional study
10
Original Article Clinicopathologic features of intraductal papillary neoplasm of breast: analyses of three cases
8
Determinants of Malignant Transformation in Fibrocystic Disease of Breast
5
Download Download PDF
10
Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates
7
Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue
7
Gene expression signature of atypical breast hyperplasia and regulation by SFRP1
18
EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies
9
The diagnosis and management of pre invasive breast disease: Pathological diagnosis – problems with existing classifications
7